search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Company insight


A leading light of life science and innovation


With the ambition of doubling revenue to $800m by 2024, Aceto is pursuing an exciting multilayered growth strategy focused on partnerships, acquisition and expansion, while staying true to its key value proposition – data-proven, quality products at competitive prices.


N


ever has it been more important to be kind to ourselves. Even prior to the pandemic, health and wellness was an upward trend, as people have become more conscious of the toll that certain food, drink and activities, or lack thereof, can have on the human body.


As a result of Covid-19, this


consciousness has exploded. From what we touch to where our food comes from, awareness of the benefits of cutting bad habits and improving the overall health of both people and the planet is booming.


expansion and acquisitions. Aceto’s Nutritional Business Unit will play a major role in achieving this ambitious target. Currently present in Europe, the US and South East Asia, the company serves 400 global customers with approximately 250 products. It has one of the largest omega-3 oils and powder portfolios in Europe, while also holding major positions in amino acids, vitamins such as coenzyme Q10, proteins including lactoferrins, and a large panel of botanical extracts. Key to Aceto’s longevity through the ages has been a localised approach.


“Under its new ownership, the plan is to double Aceto’s current annual revenue to $800m by 2024, through both organic expansion and acquisitions.”


Aceto is a key company helping to fuel this health-centric global trend. Founded in 1947, it has been a stalwart in the global ingredients and life science industry for decades, distributing and manufacturing key compounds and ingredients principally used by the pharmaceutical and nutraceutical industries. Its success has come from providing valuable solutions to global problems, acting as a significant supplier of difficult-to-source materials at fair prices.


Bespoke is best


Recent times have been characterised by excitement at Aceto. In 2019, the company was acquired by New Mountain Capital – a New York-based investment firm with a keen eye for growth opportunities. Indeed, under its new ownership, the plan is to double Aceto’s current annual revenue to $800m by 2024 through both organic


Ingredients Insight / www.ingredients-insight.com


Despite serving hundreds of companies in numerous markets globally, the company meets the bespoke needs of different countries with tailored product offerings. Indeed, its customers play a significant role in moulding its offering, the firm working consistently and tirelessly to understand their present and future requirements so that it may meet those specific needs.


This equally facilitates an ingrained focus on quality. While it may be cheaper to outsource production to the cheapest bidder, the company chooses to support local innovators in regional markets that provide differentiated products. The result is a transparent portfolio backed by proven local suppliers and products with demonstrable benefits supported by scientific data.


Its partnerships are vital, a key example in the nutrition segment being its ties with


Progress Biotech, a company that provides DHA algae that is extremely high in purity and almost tasteless – a rarity given the product in question.


2021 and beyond


Strengthening such relationships is an ongoing focus for Aceto, as the company is in the midst of preparations for a transparency audit that will further bolster its portfolio of proven products within the global market. Yet attentions have also turned to new opportunities. After observing interesting developments in vitamins K2, K6 and K2MK7 in recent times, Aceto will be re-entering the vitamins segment following almost a decade away from the space. It has recently signed an agreement with an Indian partner on L5 methyl folate calcium that will add another new dimension to its offering. Numerous other plans have also come to the fore as the company pursues significant growth. It will additionally be launching more specialised products like a nitrous, granulated form of quercetin that has been gaining traction because of its immune system health benefits. And attentions will further be turned towards digital improvements, including a website revamp and a groundbreaking ecommerce model within the next 12–24 months. Indeed, as a result of these concurrent emphases on localisation, key partnerships, expansion, acquisitions, data-proven products, new nutritional products and digital initiatives, the company looks set to take great strides on its growth journey. ●


www.aceto.com 27


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96